Skip to Content

NVR BCR (Tasigna 150 mg)

Generic Name: nilotinib

Pill with imprint NVR BCR is Red, Capsule-shape and has been identified as Tasigna 150 mg. It is supplied by Novartis Pharmaceuticals.

Tasigna is used in the treatment of chronic myelogenous leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tasigna 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR BCR

Tasigna 150 mg NVR BCR

Tasigna

Generic Name
nilotinib
Imprint
NVR BCR
Strength
150 mg
Color
Red
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals
National Drug Code (NDC)
00078-0592
Inactive Ingredients
silicon dioxide, crospovidone, lactose monohydrate, magnesium stearate, poloxamer 188, gelatin, ferric oxide red, ferric oxide yellow, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.